It is in Phase 3 via Lilly's TRIUMPH programme, with one 2026 secondary estimate placing potential MHRA approval in late 2027 or 2028 [1][2] [unverified]
This delayed gastric emptying is central to semaglutide's appetite-suppressing effects but can also contribute to reduced food intake
Its a good option for patients looking to get rid of hard to target areas like their belly, which makes it different than other weight loss programs
These agents have been investigated in peer-reviewed studies for their potential roles in glucose homeostasis and body weight management
However, there are ways to combat, minimize and alleviate their duration
Which is fortunate, since, in a highly unusual move, Showtime has brought Dexter back to life after an eight-year hiatus, and what looked like an extinction event, back in 2013